Syndax Pharmaceuticals
SNDX · NASDAQ
$13.25+$0.16 (+1.22%)TodayMarket closed ·
Prev close $13.09
Who owns SNDX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 50.4% of SNDX’s shares.
- Kynam Capital Management LP9.1%
- BlackRock Institutional Trust Company, N.A.8.0%
- State Street Investment Management (US)6.4%
- Goldman Sachs & Co. LLC6.1%
- Next 6 largest institutions20.8%
- All other shareholders49.6%
| Holder | Shares | % of shares |
|---|---|---|
| Kynam Capital Management LP | 8.05M | 9.09% |
| BlackRock Institutional Trust Company, N.A. | 7.09M | 8.00% |
| State Street Investment Management (US) | 5.66M | 6.39% |
| Goldman Sachs & Co. LLC | 5.44M | 6.14% |
| Vanguard Capital Management, LLC | 3.93M | 4.43% |
| Deerfield Management Company, L.P. | 3.78M | 4.27% |
| Eversept Partners, LP | 2.80M | 3.16% |
| BofA Global Research (US) | 2.77M | 3.13% |
| Geode Capital Management, L.L.C. | 2.58M | 2.92% |
| Hood River Capital Management LLC | 2.56M | 2.89% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| State Street SPDR S&P Biotech ETF | 3.71M | 4.19% |
| Vanguard Total Stock Market Index Fund | 2.84M | 3.21% |
| iShares Russell 2000 ETF | 2.31M | 2.60% |
| Candriam Equities L Oncology | 1.43M | 1.61% |
| Hood River Small-Cap Growth Fund | 1.21M | 1.37% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $2.12M (5 trades) of SNDX on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Metzger Michael A | Option exercise | 32.38K | — |
| Metzger Michael A | Sale | 32.38K | $784.78K |
| Metzger Michael A | Option exercise | 32.38K | $206.55K |
| Botwood Nicholas A.J. | Option exercise | 31.23K | — |
| Botwood Nicholas A.J. | Sale | 31.23K | $566.60K |
| Botwood Nicholas A.J. | Option exercise | 31.23K | $431.67K |
| Botwood Nicholas A.J. | Option exercise | 22.52K | — |
| Botwood Nicholas A.J. | Sale | 34.28K | $617.04K |
| Botwood Nicholas A.J. | Option exercise | 22.52K | $311.16K |
| Goldan Keith A. | Sale | 1.18K | $22.35K |
Short interest
Settled Sep 30, 2026
- Shares short
- 18.23M
- Days to cover
- 8.47
- % of shares outstanding
- 20.58%
- Average daily volume
- 2.15M
- Change since last report
- −11.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.